Last week, a paper by Dangour et al., published in the American Journal of Clinical Nutrition (AJCN), reported the results of an investigation into fish oil supplementation and cognition. The researchers gave a bit more than what many countries consider a minimum recommended intake of omega-3 EPA and DHA to healthy adults age 70 to 79 years, and after two years, there was no statistically significant difference in cognition between the omega-3 group and the placebo group. The press has had fun with this one.
Omega-3 EPA and DHA intake from diet were similar in both groups from the Dangour study. About one-third of each group ate white fish once a week and about one-third ate white fish more than once a week. About 12% of each group ate oily fish once a week and about 16% ate oily fish more than once a week. (Oily fish contains more omega-3, but white fish has some.) Most people in both groups ate fish with some regularity; only 8% ate it once a month or less.
The researchers here are a highly esteemed group. The study was well designed; in fact, it used a classic design in which healthy seniors were randomly selected to participate, and neither the subjects nor the researchers knew who was getting omega-3 EPA and DHA and who was getting the olive oil placebo. Unexpectedly, the results indicated no change in cognitive scores in either group over the two years. But does it mean that omega-3s have no impact on preventing cognitive decline?
Some things to consider
First, we know omega-3 EPA and DHA are important in mental health and brain function. Human studies using these omega-3s (usually more EPA) have shown good benefit for those with depression, including those at risk for suicide. They have also shown benefit in children with learning problems. DHA is particularly important, as it is selectively and critically used in brain cells and eyes. In fact, DHA’s highest concentration is in the brain and eyes, although it is found throughout the body. This study doesn’t change these facts.
Second, it is possible that omega-3 intake was already adequate in the healthy adults in the Dangour study, and taking more omega-3 didn’t make a measurable difference in just two years. In fact, omega-3 levels were not measured at study onset, although the researchers found that both groups had sufficient levels at the end of the study.
Third, the science is still young when it comes to nutrition in seniors and cognition, but some studies have reported that omega-3 EPA and DHA is associated with less risk of cognitive decline (AJCN, 2003) and less actual cognitive decline (AJCN, 2004). DHA levels from diet have also been associated with better cognitive function in middle adulthood (J Nutrition, 2010) and less risk for Alzheimer’s disease (Arch Neuro, 2003).
Some other issues
Is using a dose that is just above what several developed countries consider the daily minimum enough to make a difference, to create an intervention? The researchers intentionally used a dose (700 mg EPA and DHA) that could be consumed through regular dietary intake from about 2 servings of fish a week. Because metabolic effects are related to dose and time, perhaps the dose wasn’t enough to see a significant change over 2 years.
It’s hard to measure change when neither group declines. In this study, neither group showed cognitive decline (that could be worth celebrating!). Regarding research, however, if neither group changes, it is difficult to measure difference in change.
What if the two-year timeframe wasn’t adequate? Levels of nutrients in the brain change slowly. The brain is designed this way; for example, nutrient levels in the brain do not vary from meal to meal; this is a good thing.
It’s challenging to see immediate change with nutrition. It is possible that benefit from omega-3 EPA and DHA will not be seen for a few years. What we eat today makes a difference later. We know that with calcium and bones. Bone mass laid down in adolescence and young adulthood makes a greater difference in osteoporosis risk than calcium consumption in adulthood.
It is also possible that taking omega-3 EPA and DHA at the age of 70+ is too late. Can we replete a deficiency in the brain late in life? Adults in England clearly see value in omega-3 EPA and DHA because 43% of the nearly 14,000 persons contacted about potential participation in the study were already taking fish oil supplements and thus were excluded from participation.
It’s likely those taking fish oil were taking it for their heart or arthritis. Daily intake of 700 mg of omega-3 EPA and DHA is less than recommended for those at risk for heart disease and for those with rheumatoid arthritis looking for pain relief (with or without their RA meds); maybe 700 mg (in addition to diet consumption) isn’t enough to make a difference for the brain, measured in a 2 year period. Two years in the life of a 75 year old is very different from 2 years in the life of a child; while the brain uses nutrition at all ages, the metabolic machinery is different. Things don’t happen as fast.
I admit my bias. I have been following the omega-3 science for years. The chemical structures of these fatty acids are unique: they are slow to change in cell membranes yet serve an essential purpose in every cell in the body. And they’re tough to get into the diet of the average American, who isn’t particularly fond of fish.
We don’t know why the researchers didn’t see a change in these cognitively healthy people with 700 mg omega-3 (200 mg EPA + 500 mg DHA) in just two years. For future studies, do we need higher doses or a different ratio of EPA and DHA? Do the participants need to begin younger? Do they need to be followed longer?
Dangour et al. did not have big results, and for some that may be disappointing. It doesn’t make omega-3 fatty acids any less important for the body. It’s easy to get excited about spectacular interventions with nutrition, and just as easy to overlook the less exciting but equally important everyday nutritional requirements.
The number of people with cognitive impairment is increasing around the globe. Knowing the science as I do, I’ll hedge my bets, and continue to make sure my cognitively healthy 80-year-old mother, who has been taking fish oil for years, continues to take it. She likes to tell her friends that it keeps her brain oiled; she might be on to something.